Detalhe da pesquisa
1.
Cellular and Humoral Immunity to SARS-CoV-2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease-Modifying Therapies: A Multi-Ethnic Observational Study.
Ann Neurol
; 91(6): 782-795, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35289960
2.
Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders.
J Neurol Neurosurg Psychiatry
; 93(2): 188-195, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34711650
3.
Risk of COVID-19 infection and severe disease in MS patients on different disease-modifying therapies.
Mult Scler Relat Disord
; 60: 103735, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35398713
4.
Retinal Optical Coherence Tomography in Neuromyelitis Optica.
Neurol Neuroimmunol Neuroinflamm
; 8(6)2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34526385
5.
Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD.
Neurol Neuroimmunol Neuroinflamm
; 6(5): e583, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31355319
6.
Mortality in neuromyelitis optica is strongly associated with African ancestry.
Neurol Neuroimmunol Neuroinflamm
; 5(4): e468, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29892608